Loading...
XWAR
ONO
Market cap10mUSD
Jul 09, Last price  
0.60PLN
1D
0.00%
1Q
3.08%
Jan 2017
-46.25%
Name

Onesano SA

Chart & Performance

D1W1MN
XWAR:ONO chart
P/E
P/S
3.32
EPS
Div Yield, %
Shrs. gr., 5y
10.58%
Rev. gr., 5y
2.70%
Revenues
12m
+11.58%
1,289,0003,187,0003,499,0004,443,00010,444,00011,459,00012,124,00012,172,00010,693,00011,931,000
Net income
-5m
L-17.32%
-8,095,000-4,143,000-4,640,000-3,593,000-72,000-1,207,000-3,929,000-6,362,000-5,797,000-4,793,000
CFO
-4m
L-42.39%
-5,679,000-3,865,000-4,677,000-3,295,000-839,000-453,000-4,772,000-7,681,000-6,287,000-3,622,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1995 and based in Chorzów, Poland, onesano S.A. specializes in research and development within Poland, particularly in dietetics, animal nutrition, bioremediation, and agrotechnological processes. The company provides a range of human dietary supplements, notably under its Estrovita brand. Additionally, it offers animal health products such as Yarrowia Equinox, Yarrowia Canifelox, and Yarrowia Farminox. Its broader product portfolio encompasses various dietary supplements, food additives, functional foods, and raw materials for cosmetic use. onesano distributes its offerings through a comprehensive network including chain pharmacies, pharmaceutical wholesalers, organic/health food stores, drugstores, e-commerce platforms, zoological outlets, veterinary clinics, zoological and veterinary wholesalers, as well as directly to producers of animal feed and supplementary mixtures and contract manufacturers. The company, previously known as Skotan SA, officially adopted the name onesano S.A. in March 2023.
IPO date
Jan 11, 1999
Employees
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT